Company Name | Enterprise Value |
---|---|
Toyota Motor Corporation | 523342990027134 |
HDFC Bank Limited | 38370554430292 |
ORIX Corporation | 23646377469284 |
Sony Group Corporation | 18319601740469 |
ICICI Bank Limited | 15261237432164 |
Cracking the code
In 2024, the landscape of global enterprise value is dominated by a select few giants. Leading the pack is Toyota Motor Corporation, with an impressive enterprise value of approximately $79.94 trillion. This figure underscores Toyota's unparalleled influence in the automotive sector, accounting for nearly 26% of the combined value of the top five companies.
Honda Motor Co., Ltd. follows, holding a significant 33% of Toyota's value, showcasing its robust market presence. Sony Group Corporation, a stalwart in electronics and entertainment, commands an enterprise value of around $18.27 trillion, reflecting its diversified portfolio and innovative prowess.
HDFC Bank Limited, a major player in the financial sector, and Takeda Pharmaceutical Company Limited, a leader in healthcare, round out the top five with values of $16.09 trillion and $8.50 trillion, respectively. Together, these companies illustrate the diverse sectors driving economic growth and innovation in 2024.
These insights provide a snapshot of the economic powerhouses shaping our world in 2024, each contributing uniquely to the global market landscape.
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Healthcare Companies
Number of Employees for Top 10 Pharma Companies
Average Market Capitalization of Abbvie Annually
5 Year Trend in Market Capitalization for AbbVie
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters